Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain

British Journal of Pharmacology - Tập 146 Số 2 - Trang 189-197 - 2005
Chainllie Young1, Vesna Jevtović‐Todorović2, Yue‐Qin Qin1, Tatyana Tenkova1, Haihui Wang1, Joann Labruyere1, John W. Olney1
1Department of Psychiatry, School of Medicine, Washington University in St Louis, Campus Box 8134, 660, South Euclid, St Louis, MO 63110, U.S.A.
2‡Department of Anesthesiology, University of Virginia Health System, Charlottesville, VA, U.S.A.

Tóm tắt

Recently, it was reported that anesthetizing infant rats for 6 h with a combination of anesthetic drugs (midazolam, nitrous oxide, isoflurane) caused widespread apoptotic neurodegeneration in the developing brain, followed by lifelong cognitive deficits. It has also been reported that ketamine triggers neuroapoptosis in the infant rat brain if administered repeatedly over a period of 9 h. The question arises whether less extreme exposure to anesthetic drugs can also trigger neuroapoptosis in the developing brain. To address this question we administered ketamine, midazolam or ketamine plus midazolam subcutaneously at various doses to infant mice and evaluated the rate of neuroapoptosis in various brain regions following either saline or these various drug treatments. Each drug was administered as a single one‐time injection in a dose range that would be considered subanesthetic, and the brains were evaluated by unbiased stereology methods 5 h following drug treatment. Neuroapoptosis was detected by immunohistochemical staining for activated caspase‐3. It was found that either ketamine or midazolam caused a dose‐dependent, statistically significant increase in the rate of neuroapoptosis, and the two drugs combined caused a greater increase than either drug alone. The apoptotic nature of the neurodegenerative reaction was confirmed by electron microscopy. We conclude that relatively mild exposure to ketamine, midazolam or a combination of these drugs can trigger apoptotic neurodegeneration in the developing mouse brain. British Journal of Pharmacology (2005) 146, 189–197. doi:10.1038/sj.bjp.0706301

Từ khóa


Tài liệu tham khảo

10.1136/emj.18.1.39

10.1006/phrs.2001.0900

BERGMAN S.A., 1999, Ketamine: review of its pharmacology and its use in pediatric anesthesia, Anesth. Prog., 46, 10

10.1073/pnas.222550499

10.1016/S0022-3476(78)80072-9

10.1016/S0006-8993(96)01347-9

10.1002/cne.901460303

10.1006/nbdi.2001.0411

10.1016/0378-3782(79)90022-7

GILMAN A.G., 1990, The Pharmacological Basis of Therapeutics

10.1258/002367781780959107

10.1097/00006565-200108000-00004

10.1046/j.1460-9592.2002.00883.x

10.1126/science.287.5455.1056

10.1126/science.283.5398.70

IKONOMIDOU C., 1989, Hypobaric–ischemic conditions produce glutamate‐like cytopathology in infant rat brain, J. Neurosci., 9, 1693, 10.1523/JNEUROSCI.09-05-01693.1989

10.1213/01.ANE.0000130852.53082.D5

10.1002/(SICI)1096-9861(19990614)408:4<461::AID-CNE2>3.0.CO;2-9

10.1523/JNEUROSCI.23-03-00876.2003

10.1016/S0140-6736(73)91291-9

10.1016/S0140-6736(73)91092-1

10.1046/j.1442-200X.2003.01680.x

MOTOYAMA E.K., 1996, Smith's Anesthesia for Infants and Children

10.1016/S0165-3806(02)00279-1

10.1006/nbdi.2001.0475

10.1081/JAS-100107543

PRICE M.T., 2001, Caspase‐3 activation accompanies apoptotic but not excitotoxic neurodegeneration in the developing mouse retina and brain, Soc. Neurosci. Abs., 27, 450

10.1136/bjo.87.5.535

10.1007/BF03011442

10.1542/peds.99.2.232

10.1016/S0074-7696(08)62312-8

10.1038/sj.cdd.4401277

10.1016/j.nbd.2005.04.014

10.2174/1566524043479158

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 146 Số 2

189-197

Thông tin tác giả